|

Albipagrastim alf Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Qilu Pharmaceutical Co., Ltd.1

Indications

  • Febrile Neutropenia (FN)1
  • Pediatric Malignant Solid Tumor1
  • Neutropenia1
  • Cancer1

Other1 trial

Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.